Deliver Biosciences
8 known investors
Find your way into Deliver Biosciences
Sign up to see every warm intro you have to Deliver Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deliver Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.
Investors · 8
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
Frequently asked questions
- What does Deliver Biosciences do?
- Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.
- Who are Deliver Biosciences's investors?
- Deliver Biosciences's investors include Deep Science Ventures, CIV, Costanoa Ventures, ForgePoint Capital, Moment Ventures, Llc, Ridge Ventures, Zero Infinity Partners, ZIP.





